{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T17:08:19Z","timestamp":1776186499461,"version":"3.50.1"},"reference-count":112,"publisher":"Wiley","issue":"s95","license":[{"start":{"date-parts":[[2008,12,30]],"date-time":"2008-12-30T00:00:00Z","timestamp":1230595200000},"content-version":"vor","delay-in-days":6330,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Anaesthesiol Scand"],"published-print":{"date-parts":[[1991,9]]},"abstract":"<jats:p>Increased pulmonary vascular resistance (PVR) and microvascular hyperpermeability resulting in lung edema and arterial hypoxemia are mainstays in the development of adult respiratory distress syndrome (ARDS). The proposed pathophysiologic mechanisms include activation of complement and polymorphonuclear leukocytes secreting lysozomal enzymes, toxic oxygen metabolites (TOM) and eicosanoids. Platelets and coagulation factors are also involved, and in the most severe cases even monocytes are activated as reflected in release of thromboplastin. The latter may elicit disseminated intravascular coagulation (DIG). Under physiologic conditions lung blood flow is diverted from poorly to better oxygenated areas by way of hypoxic pulmonary vasoconstriction (HPV) thereby counteracting a decrease in arterial oxygenation. Many vasoactive substances have been proposed and again refuted as possible mediators of HPV. In this study we have focused on the following: histamine, catecholamines, arachidonates, calcium, phosphoinositides and TOM as well as endothelium\u2010derived relaxing and constricting factors. Whether HPV is present in ARDS and whether it is advantageous or not seems to depend on the stage and extent of disease. We discuss possible interactions between HPV and ARDS mediators and between HPV and various vasoactive agents tested for therapeutic effects. Out of the abundance of mediators released, prostacyclin, prostaglandin E<jats:sub>1<\/jats:sub>, activated complement and platelet activating factor have been shown explicitly to inhibit HPV whereas others are suspected of doing so. In therapeutical use, prostacyclin has proved to reduce PVR and at the same time enhance cardiac output and oxygen delivery. In mild to moderate ARDS, improvement of arterial oxygenation has also been obtained employing almitrine bismesylate, a potentiator of HPV. Experimentally, adenosine effectively reduces increments in PVR and microvascular permeability with modest effects on systemic circulation. However, further investigations are warranted to decide whether adenosine or more specific blockers as, for instance, monoclonal antibodies against tumor necrosis factor should be integrated in ARDS therapy in the future.<\/jats:p>","DOI":"10.1111\/j.1399-6576.1991.tb03399.x","type":"journal-article","created":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T03:22:40Z","timestamp":1230780160000},"page":"40-54","source":"Crossref","is-referenced-by-count":12,"title":["Hypoxic pulmonary vasoconstriction in the adult respiratory distress syndrome"],"prefix":"10.1111","volume":"35","author":[{"given":"Ase","family":"Jolin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Bjertn\u00e6s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,12,30]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0272-5231(21)00143-X","article-title":"Structural alterations of lung parenchyma in the adult respiratory distress syndrome","volume":"3","author":"Bachhofen M","year":"1982","journal-title":"Clin Chest Med"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1946.tb00389.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1011444"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(63)90062-0"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.38.4.221"},{"key":"e_1_2_1_7_2","first-page":"H541","article-title":"Adenosine and pulmonary vasodilation","volume":"247","author":"Gottlieb JE","year":"1984","journal-title":"Am J Physiol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1977.tb01203.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.22.3.385"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1152\/jappl.1969.26.6.693","article-title":"Prevention of hypoxic pulmonary vasoconstriction in cat lung by histamine\u2010releasing agent 48\/80","volume":"26","author":"Hauge A","year":"1969","journal-title":"J Appl Physiol"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/00039896.1966.10664468"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107142"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.18.4.366"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.25.6.747"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.1969.sp002014"},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1152\/ajplegacy.1967.213.4.990","article-title":"Effect of adrenergic blockade on hypoxia induced pulmonary vasoconstriction in awake dogs","volume":"213","author":"Thilenius OG","year":"1967","journal-title":"Am J Physiol"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.22.3.371"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0034-5687(73)90093-5"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1964.sp007362"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0034-5687(75)90022-5"},{"key":"e_1_2_1_21_2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0022-5223(19)40113-X","article-title":"The effects of dopamine and isoproterenol on the pulmonary circulation","volume":"71","author":"Mentzer R M","year":"1976","journal-title":"Thorac Cardiovasc Surg"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/51.4.303"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.23.1.19"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1967.22.3.402"},{"key":"e_1_2_1_25_2","first-page":"869","article-title":"Effects of isoproterenol on distribution of ventilation and perfusion in asthma","volume":"107","author":"Chick TW","year":"1973","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BFb0030496"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02179338"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0034-5687(78)90041-5"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02101579"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.71.2_Supplement.263"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.71.2.249"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1139\/y85-034"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.185.4157.1181"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1975.tb10030.x"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1976.41.5.714"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1978.tb06061.x"},{"issue":"1","key":"e_1_2_1_37_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1152\/jappl.1982.53.1.44","article-title":"Strength of hypoxic vasoconstriction determines shunt fraction in dogs with atelectasis","volume":"53","author":"Thomas HM","year":"1982","journal-title":"J Appl Physiol"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1985.59.1.72"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1164\/arrd.1983.127.5.566"},{"key":"e_1_2_1_40_2","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1152\/jappl.1984.56.5.1340","article-title":"Leukotriene\u2010synthesis and receptor blockers block hypoxic pulmonary vasoconstriction","volume":"56","author":"Morganroth ML","year":"1984","journal-title":"J Appl Physiol"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/139.1.100"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0704(18)30439-1"},{"key":"e_1_2_1_43_2","first-page":"262","article-title":"Action of leukotriene LTC4 on the calcium channels of the somatic membrane of the nerve cell and tone of smooth muscle organs","volume":"21","author":"Skryma RN","year":"1989","journal-title":"Neirofiziologiia"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.38.2.99"},{"key":"e_1_2_1_45_2","first-page":"81","article-title":"Prevention and reversal of hypoxic pulmonary hypertension by calcium antagonists","volume":"130","author":"Steinbrook HS","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_46_2","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1152\/jappl.1986.60.3.942","article-title":"Pulmonary vascular tone is increased by a voltage\u2010dependent calcium channel potentiator","volume":"60","author":"Tolins M","year":"1986","journal-title":"J Appl Physiol"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1985.59.1.113"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.55.2.197"},{"key":"e_1_2_1_49_2","first-page":"923","article-title":"Hypoxia alters membrane potentials in rat main pulmonary arteries (abstract)","volume":"43","author":"Hottenstein OD","year":"1984","journal-title":"Federation Proc"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01870664"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198703000-00008"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1987.tb02521.x"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1978.tb01340.x"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198605000-00004"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198605000-00005"},{"key":"e_1_2_1_56_2","first-page":"H721","article-title":"Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation","volume":"252","author":"Burke TM","year":"1987","journal-title":"Am J Physiol"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)68544-3"},{"key":"e_1_2_1_58_2","unstructured":"Kj\u00e6veJ VaageJ Bjertn\u00e6sL.Factors governing the vascular and airway reponses induced by toxic oxygen metabolites in isolated perfused rat lungs. Role of proteases complement and arachidonic acid metabolites. In manuscript."},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1986.250.3.C406"},{"key":"e_1_2_1_60_2","first-page":"A53","article-title":"Endothelial cell\u2010derived relaxing factor and vascular free radical metabolism","volume":"139","author":"Beckman JS","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_61_2","first-page":"241","volume-title":"Acute respiratory failure, in the series Lung Biology in Health and Disease","author":"Zapol WM","year":"1985"},{"key":"e_1_2_1_62_2","first-page":"358","article-title":"State of the art review. Pathogenesis of pumonary edema","volume":"109","author":"Staub N C","year":"1974","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_63_2","first-page":"1","article-title":"Importance of hypoxic pulmonary vasoconstriction with atelectasis","volume":"8","author":"Marshall B E","year":"1982","journal-title":"Adv Shock Res"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1980.tb01517.x"},{"key":"e_1_2_1_65_2","first-page":"537","article-title":"Acute generalized microvascular injury by activated complement and hypoxia: the basis of the adult respiratory distress syndrom and multiple organ failure?","volume":"67","author":"Nuytinck JK","year":"1986","journal-title":"Br J Exp Pathol"},{"key":"e_1_2_1_66_2","first-page":"516","article-title":"Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with cystic fibrosis and cor pulmonale","volume":"130","author":"Michael JR","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_67_2","first-page":"275","volume-title":"Acute respiratory failure, in the series Lung Biology in Health and Disease","author":"Greene R","year":"1985"},{"key":"e_1_2_1_68_2","first-page":"23","volume-title":"Acute Respiratory failure, in the series Lung Biology in Health and Disease","author":"Jones R","year":"1985"},{"key":"e_1_2_1_69_2","first-page":"112","article-title":"The pulmonary vascular lesions of the adult respiratory distress syndrome","volume":"112","author":"Tomashefski JF","year":"1983","journal-title":"Am J Pathol"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1980.tb06586.x"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1975.38.5.846"},{"key":"e_1_2_1_72_2","first-page":"645","article-title":"The role of activated complement and granulocytes in shock states and myocardial infarction","volume":"29","author":"Jacob H S","year":"1981","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/0300-9572(86)90004-3"},{"key":"e_1_2_1_74_2","first-page":"215","volume-title":"Progress in clinical and biological research, vol. 236 B. First Vienna shock forum","author":"Bjertn\u00e6s L","year":"1987"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110123"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-6980(75)80009-8"},{"key":"e_1_2_1_77_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0022-3565(25)21907-3","article-title":"Differential response of the pulmonary circulation to prostaglandins E2 and F2a, in the presence of unilateral alveolar hypoxia","volume":"229","author":"Sprague RS","year":"1984","journal-title":"J Pharm Exp Therapy"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198408000-00008"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198009000-00003"},{"key":"e_1_2_1_80_2","first-page":"1257","article-title":"Relationship of increased lung serotonin levels to endotoxin\u2010induced pulmonary hypertension in sheep: Effect of a serotonin antagonist","volume":"132","author":"Demling RH","year":"1985","journal-title":"Amer Rev Respir Dis"},{"key":"e_1_2_1_81_2","first-page":"65","article-title":"The effect of ketanserin on hypoxia\u2010induced vasoconstriction in isolated lungs","volume":"5","author":"Helgesen K G","year":"1986","journal-title":"Int J Microcirc: Clin Exp"},{"key":"e_1_2_1_82_2","unstructured":"AshbaughD G.Respiratory distress syndrome. Respiratory diseases. National Institute of Health. DHEW Publication 1972: No 73\u2013432:165\u2013180."},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00295985"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1958.sp006082"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-198802000-00023"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-198605000-00007"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-197210000-00009"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/0034-5687(83)90121-4"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198204153061504"},{"key":"e_1_2_1_90_2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0022-3565(25)38915-9","article-title":"Impact of platelet activating factor on vascular responsiveness in isolated rat lungs","volume":"236","author":"Gillespie MN","year":"1986","journal-title":"J Pharmacol Exp Therapy"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198812000-00005"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198709001-00548"},{"key":"e_1_2_1_93_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/139.1.111"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/137.5.1062"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198801000-00030"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-197906000-00003"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198904000-00008"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198108000-00006"},{"key":"e_1_2_1_99_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/139.1.106"},{"key":"e_1_2_1_100_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199002000-00005"},{"key":"e_1_2_1_101_2","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1152\/jappl.1984.56.5.1246","article-title":"Prostaglandin I2 supports blood flow to hypoxic alveoli in anesthetized dogs","volume":"56","author":"Sprague RS","year":"1984","journal-title":"J Appl Physiol"},{"key":"e_1_2_1_102_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198311000-00012"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/136.5.1232"},{"key":"e_1_2_1_104_2","first-page":"421","article-title":"Effect of vasodilator treatment on the resolution of oleic acid injury in dogs","volume":"131","author":"Bishop MJ","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1985.tb02231.x"},{"key":"e_1_2_1_106_2","first-page":"78","article-title":"Methylprednisolone inhibits hypoxic pulmonary vasoconstriction in man (abstract)","volume":"3","author":"Vaage J","year":"1984","journal-title":"Int J Microcirc: Clin Exp"},{"key":"e_1_2_1_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-1383(84)80002-9"},{"key":"e_1_2_1_108_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110123"},{"key":"e_1_2_1_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/0888-6296(89)90776-X"},{"key":"e_1_2_1_110_2","unstructured":"HelsetE JolinA Kj\u00e6veJ DahlP E Bjertn\u00e6sL.The effect of exogenously administered adenosine on pulmonary hemodynamics and fluid filtration rate after lung injury (abstract).Int J Microcirc: Clin Exp1990: In press."},{"key":"e_1_2_1_111_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198503000-00001"},{"key":"e_1_2_1_112_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00260878"},{"key":"e_1_2_1_113_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198702123160705"}],"container-title":["Acta Anaesthesiologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-6576.1991.tb03399.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-6576.1991.tb03399.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T17:42:11Z","timestamp":1738863731000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-6576.1991.tb03399.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,9]]},"references-count":112,"journal-issue":{"issue":"s95","published-print":{"date-parts":[[1991,9]]}},"alternative-id":["10.1111\/j.1399-6576.1991.tb03399.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-6576.1991.tb03399.x","archive":["Portico"],"relation":{},"ISSN":["0001-5172","1399-6576"],"issn-type":[{"value":"0001-5172","type":"print"},{"value":"1399-6576","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,9]]}}}